scispace - formally typeset
K

Kay E. Davies

Researcher at University of Oxford

Publications -  580
Citations -  40236

Kay E. Davies is an academic researcher from University of Oxford. The author has contributed to research in topics: Duchenne muscular dystrophy & Dystrophin. The author has an hindex of 100, co-authored 573 publications receiving 38462 citations. Previous affiliations of Kay E. Davies include Case Western Reserve University & Technische Universität München.

Papers
More filters
Journal ArticleDOI

G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.

TL;DR: The data confirm the close evolutionary relationships between the DMD and utrophin loci; however, the functions for the corresponding proteins probably differ.
Journal ArticleDOI

Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy

TL;DR: The results show that dystrobrevin-deficiency is a generic feature of dystrophies linked to Dystrophin and the dystrophicin-associated proteins, the first indication that a cytoplasmic component of the dyStrophin- associated protein complex may be involved in the pathogenesis of limb-girdle muscular dystrophy.
Journal ArticleDOI

The role of utrophin in the potential therapy of Duchenne muscular dystrophy

TL;DR: Interest in the identification and manipulation of important regulatory regions and/or molecules that increase the expression of utrophin and their delivery to dystrophin-deficient tissue and as pre-existing cellular mechanisms are utilized, this approach would avoid many problems associated with conventional gene therapies.
Journal ArticleDOI

The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy

TL;DR: Within pre-mutation carriers of FraX, ageing, increases in the number of CGG trinucleotide repeats and decreases in %FMRP(+) lymphocytes were associated with decreasing voxel density of regions previously identified as decreased relative to controls, suggesting, for the first time, an association between voxels density reduction and genetic variation in FraX.
Journal ArticleDOI

In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.

TL;DR: MRI could identify cardiac abnormalities in the RV of mdx mice as young as 1 month, and detected myocardial fibrosis at 6 months, believed to be the earliest MRI measurements of cardiac function reported for any mice, and the first use of late-gadolinium-enhancement in a mouse model of congenital cardiomyopathy.